PMLiVE | Pharmaceutical industry news, articles, jobs, reports, …
WEBRoche’s Genentech acquires Regor Pharmaceuticals’ CDK inhibitors for $850m upfront. Novo Nordisk and NanoVation to develop genetic medicines in partnership worth $600m. Sanofi, RadioMedix and Orano Med partner to develop rare cancer therapy in deal worth €320m. Gilead and AI-focused Genesis partner to develop small molecule therapies.
PME - PMLiVE
WEBPharmaceutical Market Europe – October 2023. Launch excellence – adapting to data disruption; preparing for the clinical trials of the future; the impact of cell therapies on cancer treatments.
Sales - PMLiVE
WEBEli Lilly and Genetic Leap partner to develop RNA-targeted therapies in deal worth $409m. Sep 10, 2024 | News, Sales. The companies will use Genetic Leap’s AI platform to generate oligonucleotide drugs against targets selected by Lilly. Read More.
Eli Lilly and Radionetics Oncology enter $140m radiopharma …
WEBJul 2, 2024 · Eli Lilly has agreed to pay Radionetics Oncology $140m upfront to partner on the biotech’s G protein-coupled receptor (GPCR)-targeting small-molecule radiopharmaceuticals.
PME - Articles - Pharmaceutical Market Europe
WEBSep 11, 2024 · PME - Articles. TL STRADOO - Digital biomarkers: reinventing patient monitoring and care. 11 September 2024 Communique - Marketing & Comms. Read More. GLOBAL HEALTH - Causes That Count, Health’ report – key issues affecting global health. 11 September 2024 Communique - Marketing & Comms. Read More.
Bristol Myers Squibb’s Krazati granted FDA accelerated approval in ...
WEBJun 24, 2024 · Bristol Myers Squibb’s (BMS) KRAS inhibitor Krazati (adagrasib) has been granted accelerated approval by the US Food and Drug Administration (FDA) as part of a combination treatment for a subset of colorectal cancer (CRC) patients.
FDA publishes new guidelines for COVID-19 vaccine approval
WEBOct 9, 2020 · The US Food and Drug Administration (FDA) has released new guidance detailing how it will grant emergency use authorisations (EUA) to COVID-19 vaccines.
Healthcare Archives - PMLiVE
WEBThe Generation Study is aiming to screen 100,000 newborns for more than 200 diseases. Read More
PME - Home
WEBHow AI and digital innovations can help agencies and pharma support HCPs in the fight against COVID-19 - PME Supplement August 2020. As the realities of COVID-19 hit and lockdown restrictions came into force around the world, agencies and pharma suddenly found themselves embracing AI and digital innovations at an accelerated rate.
Regeneron to acquire Decibel Therapeutics in deal worth up to …
WEBAug 10, 2023 · Regeneron Pharmaceuticals has entered into a definitive agreement to acquire hearing loss specialist Decibel Therapeutics in a deal worth as much as $213m. The transaction gives Regeneron access to investigational gene therapy, DB-OTO, which is designed to provide hearing to people with otoferlin-related hearing loss.